for July 2018
12 Common situations in #nursinghomes in which antibiotics are not indicated 🙅♀️💊
— Brad Langford (@BRxAD) July 10, 2018
via https://t.co/yzBRajZZAn#LTC #AntimicrobialStewardship #saveABX pic.twitter.com/Oi4wimB74v
A new article by @emilylheil @jasonroberts_pk and Dr. Nicolau in @ASMicrobiology
— Antibiotic Steward (@ABsteward) July 2, 2018
PK/ PD based antibiotic dosing calculator provides beta-lactam doses with high likelihood of PTA in critically ill patients. Great work. @SIDPharm @accpinfdprnhttps://t.co/s1UOqb2IoY pic.twitter.com/8PTU3l9pCk
A new 💥 sytematic review and network meta-analysis just published in @TheLancetInfDis:
— Antibiotic Steward (@ABsteward) July 17, 2018
Comparative efficacy of treatments for Clostridium difficile infection.
Metronidazole should NOT be recommended for treatment of C difficile infection. https://t.co/d5cZ1NZKF2 pic.twitter.com/30XgkUJmUw
New @US_FDA Labeling for Fluoroquinolone Antibiotics 📢📢: FDA Requires Labeling Changes Due to Low Blood Sugar Levels and Mental Health Side Effects. @SIDPharm @accpinfdprn @manfordou @IDstewardship @CIDRAP_ASP https://t.co/muGDO95Zfe
— Antibiotic Steward (@ABsteward) July 10, 2018
Given limited treatment options for CRE infections, A new review article in Annals of Pharmacotherapy about potential role of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae. https://t.co/haUucwTURC pic.twitter.com/fdunykuIVh
— Antibiotic Steward (@ABsteward) July 19, 2018
Accepted manuscript in press:
— Diane Ashiru, PhD (@DrDianeAshiru) July 2, 2018
Development of consensus based national antimicrobial stewardship competencies for UK undergraduate healthcare professional education https://t.co/LYFyyTPe8D #UKCPAPINJC #AntibioticGuardian cc @rpharms pic.twitter.com/cmGh8nTUWn
NEW 💥💥 in @ASMicrobiology Past and Present Perspectives on β-Lactamases : Dr. Karen Bush.
— Antibiotic Steward (@ABsteward) July 30, 2018
A must read! @SIDPharm @accpinfdprn @InfectiousDz #foamed #antibioticstewardhttps://t.co/OJd8gbdDeE pic.twitter.com/ABJISbdveV
New in CID: Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics? https://t.co/k8LCOxMt0H pic.twitter.com/lHsokMI95O
— Antibiotic Steward (@ABsteward) July 10, 2018
New @TheLancet: Outbreak of #Ebola virus disease in the Democratic Republic of the Congo, April–May, 2018: an epidemiological study https://t.co/C14OUSjgFm
— The Lancet Infectious Diseases (@TheLancetInfDis) July 1, 2018
A very interesting article 💥 just published in CID:Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. A must read!! https://t.co/iaPWyrh68v pic.twitter.com/PDRyztlq4C
— Antibiotic Steward (@ABsteward) July 23, 2018
A new article 💥 @BSACandJAC
— Antibiotic Steward (@ABsteward) July 26, 2018
By Dr.Srinivasan:Trends in antifungal use in US hospitals, 2006–12 : Antifungals were most frequently used in ICU & fluconazole accounted for a large, but declining, proportion overtime. #JACnews#Antifungalstewardship https://t.co/nyccWnYo3m pic.twitter.com/BofNStQitT
A new 💥 article by our @SIDPharm members @KaseyPharmD @LisaIDpharmD showing the Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections. #foamed #antibioticstewardship https://t.co/HwLKAN91yW pic.twitter.com/UuTTtJtZwQ
— Antibiotic Steward (@ABsteward) July 28, 2018
NEW! Delafloxacin: A New Anti-MRSA Fluoroquinolone. A new review article just published in CID 🤔
— Antibiotic Steward (@ABsteward) July 28, 2018
Interesting discussion about formulary addition and its place in therapy. https://t.co/fhiFusgoLZ pic.twitter.com/hp42qEZPSY
Excited that our article on the "state of the state" of #AntimicrobialStewardship is out! We explore current challenges, successes and future directions for the field: https://t.co/LCud98ZvX6 #antimicrobialresistance pic.twitter.com/2xllowxB27
— Mike Stevens (@Dr_Mike_Stevens) July 1, 2018
Today I announced new efforts #FDA is taking to advance antimicrobial stewardship in veterinary settings: https://t.co/pqcAZKpyaJ Antimicrobial resistance is a global public health challenge. It’s critical we implement good stewardship in human healthcare & veterinary settings
— Scott Gottlieb, M.D. (@SGottliebFDA) July 31, 2018
⭐️ This may be the MOST important factor in #abxstewardship today. Longevity, sustainability, and organizational culture are critical elements. We need long-term solutions to persistent problems. #SocialScienceMatters 📲 https://t.co/iC1rJ6y8LR in @BSACandJAC #SaveABX pic.twitter.com/W5fu0TKNKc
— Tim Gauthier (@IDstewardship) July 26, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): RCT. 48% reduction in symptomatic UTI over 12 months. https://t.co/MzfjXCfBqc
— David Paterson (@davidantibiotic) July 12, 2018
📄 Only 11 of 2,500 studies met inclusion criteria, seems like we may need more data from the ICU. At least what we have doesn’t look negative 📲 https://t.co/VZy8MMMYFh via @IDSAInfo ...Pharmacists are key members to ICU team for abx stewardship. #DrugReview #PharmICU pic.twitter.com/Zyf9cZJo4X
— Tim Gauthier (@IDstewardship) July 6, 2018
'Doctors & vets working together for antibiotic stewardship' BMJ feature #StopSuperbugs #OneHealth #amtimicrobialresistance https://t.co/qd8RGZ0Ywz
— Antibiotic Action (@TheUrgentNeed) July 16, 2018
👌🏼📄💉👾🔬✅😷🙂
— Tim Gauthier (@IDstewardship) July 4, 2018
This looks like a good one! These authors, they are definitely experts on the topic! New in @AJHPOfficial with @TheIDApprentice @TimbrookTT @real_idpharmd @manfordou @shawnmacv (all on twitter!) 📲 https://t.co/e2Gd7RgBG1 #RapidDiagnostics #ToolsForStewardship pic.twitter.com/abxiWa5Pco
A new article in OFID by @OncIDPharmd
— Antibiotic Steward (@ABsteward) July 13, 2018
Clinical outcomes associated with linezolid resistance in leukemia patients with linezolid-resistant Staphylococcus epidermidis bacteremia. Linezolid resistance was identified in 40% leukemia patients.
https://t.co/YMzGEO1C2R pic.twitter.com/EGqFLlJM5M
❇️ Consultant Antimicrobial Pharmacist ❇️ @AneurinBevanUHB now @NHS_Jobs see https://t.co/Gpfba9zei1 Our 1st consultant post @ABUHB_Rx will lead a team of pharmacists to deliver #antimicrobialstewardship and @WelshGovernment #AMR & #HCAI targets across primary &secondary care pic.twitter.com/csgUboZF9z
— Jonathan Simms (@jon_simms) July 18, 2018
The emergence of antibiotic-resistant bacterial superbugs is a ticking time bomb that threatens our very way of life. Despite this, Novartis announced it is dropping out of the antibiotics game. @gizmodo https://t.co/7cW4ATgMrY
— IDSA (@IDSAInfo) July 12, 2018
SIDP joins over 30 organizations in support of the Re-Valuing Antimicrobial Products (REVAMP) Act, a novel approach to incentivize development of urgently needed new antimicrobials and responsible stewardship of them. Learn more about this legislation: https://t.co/kOB0CY2Pie pic.twitter.com/8hOi41fPyO
— SIDP (@SIDPharm) July 27, 2018
A new article in OFID by @IDPharmProf
— Antibiotic Steward (@ABsteward) July 10, 2018
A simple, behavioral nudge in microbiology reporting was associated with a 5.5-fold increased odds of de-escalation of broad spectrum antibiotics in pneumonia and reduced Acute kidney injury. https://t.co/Dm6vrBDyOs pic.twitter.com/haDNUcadBy
An @ECDC_EU study compared the burden of 31 #infectious #diseases - ranking them based on #surveillance data & each diseases’ incidence, mortality & morbidity in a single metric, DALYs. Do you know which disease is #1? #INFLUENZA @beatflu @NHSflufighter https://t.co/LVLnqRlLZj pic.twitter.com/GF39sD0S6f
— Melvin Sanicas, MD (@Vaccinologist) July 19, 2018
The @US_FDA just added additional warnings related to Fluoroquinolone use - hypoglycemia and additional mental health side effects. A few more reasons to pick more appropriate alternatives!!!#StopSuperBugs #Stewardship https://t.co/lg5wEgXuKO pic.twitter.com/gPokPFGQyi
— Travis Jones (@tmjones6) July 10, 2018
Treatment with antibiotics, PPIs, and underlying co-morbidities were important Predictors of mortality among a national cohort of Veterans with recurrent Clostridium difficile infection. A new article by @Kerry_LaPlante in OFID https://t.co/7bxwKE2nNp pic.twitter.com/BkpW6dDy2h
— Antibiotic Steward (@ABsteward) July 19, 2018
Lefamulin: Review of a promising novel pleuromutilin antibiotic. A new review article by @jwagsIDPharmD in @PharmacoJournal@SIDPharm @accpinfdprn https://t.co/Osz26VwLHv pic.twitter.com/SDgd4Mn4l9
— Antibiotic Steward (@ABsteward) July 18, 2018
Beware Biofilms! 95% of hospital surfaces contaminated with dry surface biofilms: likely to drive extended survival of vegetative bacteria, misleading results from surface sampling, and reduced susceptibility to cleaning and disinfection! https://t.co/oz995db1Dj
— Jon Otter (@jonotter) July 20, 2018
New📢📢. Just released @CIDRAP_ASP webinar: "Antibiotic prescribing & opportunities for antibiotic stewardship in different outpatient settings," Dr. Katherine Fleming-Dutra, MD @CDCgov @SIDPharm @accpinfdprn @TheFebrileMuse @InfectiousDz @battlesuperbugshttps://t.co/zApeYkqmzB
— Antibiotic Steward (@ABsteward) July 30, 2018
Far too Often, Antibiotics Are Unnecessarily Prescribed for Common Respiratory Conditions in Outpatient Settings, Particularly in Urgent Care. A new study just published in @JAMA_current @JAMAInternalMed
— Antibiotic Steward (@ABsteward) July 16, 2018
By Dr.Hicks @CDCgovhttps://t.co/SJ3j5sTOJY pic.twitter.com/aE5asLdTId
#EU set to ban routine prophylactic use of antibiotic-medicated #livestock feed. #OneHealth #AMR #AntimicrobialResistance #AntibioticResistance #AntimicrobialStewardship https://t.co/9hj3Iodb5t #agriland
— Laura Higham (@L_Higham) July 12, 2018
A new 💥💥study by Dr. Nicolau @SIDPharm confirms potent in vitro activity of Ceftazidime/avibactam plus aztreonam
— Antibiotic Steward (@ABsteward) July 23, 2018
against CPE expressing multiple β-lactamases. https://t.co/gpnRvMjiIX pic.twitter.com/K3qjYBhJYi
Sepsis is recognised by @WHO as the final common pathway to death from most infectious diseases worldwide. Cases like these, courtesy of @Telegraph, illustrate why it's absolutely critical we work together to fight antimicrobial resistance: https://t.co/qvlVUc21Be
— Dr. Ron Daniels BEM (@SepsisUK) July 9, 2018
New guideline for Abx💊 Use in Adults with CAP👾 by the Korean🇰🇷 Society of Infectious Diseases & Korean Society for Chemotherapyhttps://t.co/VzHi0cJPJi pic.twitter.com/PGaTwUw3NF
— Antibiotic Tweets (@khalideljaaly) July 7, 2018
Great review by @UNMC_ID Fellow @raj_karnatak for ID Journal Club - BLASTing Inappropriate Allergies out of the EMR with Antimicrobial Stewardship https://t.co/Fnt9TtZp67 @KellyCawcuttMD @DrJRMarcelin @M_Salman_Ashraf @bergmanscott @RandyMcCreery @RichardJHankins @LRearigh
— UNMC ID (@UNMC_ID) July 19, 2018
Medical Clinics ahead of press issue on Antimicrobial Stewardship from visiting editor Chet Cunha of @BrownUniversity https://t.co/b7OnuQ9OHx pic.twitter.com/Y2At8FjcRb
— Tristan Timbrook (@TimbrookTT) July 15, 2018
Antimicrobial Stewardship and Intensive Care Unit (ICU) Mortality: A systematic review | Clinical Infectious Diseases | Oxford Academic https://t.co/WLyL6jYyza
— Abid Hussain (@MicrobLog_me_uk) July 4, 2018
Hey @julie_justo way to hold down a pharm presence! Fellows def need training. Hard thing w/ stewardship being so complex: education, systems analysis/ optimization, team building, leadership, data mining, composing reports, politics, graphic design... 📲 https://t.co/0e5ATvQli6 pic.twitter.com/Hcrig1ztob
— Tim Gauthier (@IDstewardship) July 16, 2018
Registrations are open for the National Antimicrobial Resistance and Stewardship Forum at the University of Melbourne on 1 and 2 November. Register for the symposium on 2 Nov, and workshops on 1 Nov: https://t.co/LD5LfZTtCV pic.twitter.com/1BRT6iX1fu
— NCAS_Australia (@NCAS_Aus) July 6, 2018
V. cholerae outer membrane vesicles inhibit bacteriophage infection by acting as natural decoys @JBacteriology https://t.co/ruq8P3gfCJ pic.twitter.com/jhcSylFgeY
— ASM (@ASMicrobiology) July 13, 2018
From our partners @WHO & @UNICEF:
— Gavi (@gavi) July 18, 2018
A record 9 in 10 infants worldwide (123 MILLION total) received at least one dose of diphtheria-tetanus-pertussis vaccine in 2017, protecting them from deadly infectious diseases.#VaccinesWork ! https://t.co/ANEjxZvDer
A global network of 145 laboratories established by the Global Polio Eradication Initiative, also tracks measles, rubella, yellow fever, meningitis, and other deadly infectious diseases. #endpolio https://t.co/jdxwpDfZBh pic.twitter.com/K7QGV04ixS
— Rotary International (@Rotary) July 11, 2018
By implementing and maintaining Antimicrobial stewardship principles in every patient encounter we can help decrease improper use of antibiotics. https://t.co/zh1LHw6Jzp pic.twitter.com/AAr34LGNZb
— Coastal Telehealth Specialists (@CoastTelehealth) July 6, 2018
Opportunities for improvement of #antimicrobialstewardship
— Brad Langford (@BRxAD) July 1, 2018
research
1) ITS or cRCT are ideal
2) report intended and unintended outcomes
3) report detailed process evaluation of intervention implementationhttps://t.co/qxFtPb4umi
#InfectiousDiseases A-Z: Viral respiratory infections like sore throats, the common cold, ear infections and bronchitis, are caused by #viruses. So when you go to Urgent Care, don't expect #antibiotics. They won't help. https://t.co/wEvAy4k6Om pic.twitter.com/1wl5KCfcOw
— Mayo Clinic (@MayoClinic) July 25, 2018
Up to date systematic review from Mark Wilcox and colleagues. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis https://t.co/t2gv3G8ORR
— David Paterson (@davidantibiotic) July 17, 2018
📄 New in @AJHPOfficial on the cost-effectiveness estimates with C diff treatments 📲 https://t.co/z6frB4TVLa ... vanco PO 👍🏼 #Cdiff #Cdifficile via @ASHPOfficial pic.twitter.com/MabU3szfnu
— Tim Gauthier (@IDstewardship) July 25, 2018
New drug uses immune system to wipe out deadly bacteria: antibiotic-resistant bacteria are among those targeted by new ‘immunobiotic’ #StopSuperbugs https://t.co/Fkwj1OznY8
— Antibiotic Action (@TheUrgentNeed) July 6, 2018
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents | Clinical Infectious Diseases | Oxford Academic https://t.co/3GffKVeiGS
— David Paterson (@davidantibiotic) July 27, 2018
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.